To continue using FE Trustnet please choose an edition:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
Share   Print      RSS

United Drug PLC (UDG)

United Drug PLC

Notice of Interim Management Statement
RNS Number : 1568X
United Drug PLC
05 February 2013
 

United Drug plc

Notice of Interim Management Statement

5 February 2013: United Drug plc (the "Company") will issue an Interim Management Statement at 7:00 a.m. on Tuesday, 12 February 2013.

 

The Company will also host a conference call for investors and analystsat 9.00am (BST) on Tuesday, 12 February 2013 to discuss this statement. The dial-in details are as follows:

 

UK/International:          +44 (0) 20 3003 2666

Republic of Ireland:       +353 (0) 1 800 930 488

Access Code:               4058442

 

A playback facility will be available for seven days on +44 (0) 20 8196 1998 (UK) or 00 353 (0) 1 486 4035 (Republic of Ireland). The access code for the replay will be 4058442.

 

ENDS             

 

Contact:

Karen Geoghegan

Tel: +353-1-4637720

 

 

About United Drug plc

 

Listed on the London Stock Exchange, United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including the UK, Ireland, Germany, the Netherlands, Belgium, and the US. 

 

The Company operates across three divisions, Sales, Marketing & Medical, Healthcare Supply Chain and Packaging & Specialty.

 

In the Sales, Marketing & Medical division United Drug is a global leader in the provision of contract sales outsourcing services to pharmaceutical manufacturers with operations in major markets including Continental Europe, the UK, North America and a presence in South America. United Drug also provides related marketing services to pharmaceutical manufacturers in many of these markets.

 

In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. Through its medical & scientific operations, United Drug provides sales & marketing and technical service solutions, including contract distribution services to a wide range of medical & scientific equipment & consumable manufacturers, with a market leading position in Ireland and the UK.

 

In the Packaging & Specialty division United Drug is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, Dutch and Belgian markets. The Company also provides speciality distribution and homecare services in the UK and Ireland.

 

For more information go to www.united-drug.com. 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFFFIFDSEIE